iLite® Etanercept NAb positive control, Reagent

iLite ® Etanercept NAb positive control Reagent
SKU
WIEBM3177
Packaging Unit
75 µL
Manufacturer
Svar Life Science / Eurodiagnostica

Availability: loading...
Price is loading...
The iLite® Etanercept NAb positive control can be used as a positive control for neutralizing antibodies against Etanercept. Tumor necrosis factor alpha (TNF-alpha) promotes inflammatory responses, which, in turn, contribute to the clinical problems associated with many inflammatory disorders, including rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriasis and refractory asthma. These diseases are sometimes treated with TNF-alpha inhibitors, including infliximab, adalimumab, etanercept, certolizumab pegol or golimumab. Prolonged therapies with these TNF-alpha inhibitors may lead to development of neutralizing antibodies (NAbs), which may counteract the TNF-alpha antagonist activity of the drugs.
More Information
SKU WIEBM3177
Manufacturer Svar Life Science / Eurodiagnostica
Manufacturer SKU BM3177
Package Unit 75 µL
Quantity Unit PAK
Product information (PDF) Download
MSDS (PDF) Download